$NMRD News
Last published 2y ago
- 2y agoSYTHTCRHOURFUBO+7CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICAPR NewswireAnthony, Linder & Cacomanolis, PLLC is proud to announce that Partner Craig D. Linder has been selected to the 2024 Top 50 Lawyers in America list...
- 2y agoNMRDImportant Update on Listing Status and Strategic DirectionGlobeNewswireLoughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a
- 2y agoNMRDNemaura Medical Inc. Receives Positive Nasdaq Listing DecisionGlobeNewswireLoughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ:NMRD) ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is
- 2y agoNMRDNemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic GrowthGlobeNewswireLoughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ:NMRD) ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is
- 2y agoBURUBYRNCTXRCVGI+20Sidoti Events, LLC's Virtual November Micro-Cap ConferenceACCESS NewswireNEW YORK, NY / ACCESSWIRE / November 14, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking
- 2y agoNMRDNemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsGlobeNewswireCompany CEO to discuss development at 1pm EST on 15th November 2023, at the Sidoti Virtual Investor Conference Loughborough, UK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, developer of a daily wear
- 2y agoNMRDNemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business UpdateGlobeNewswireLoughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable,
- 3y agoNMRDNemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.GlobeNewswireLOUGHBOROUGH, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic
- 3y agoNMRDNemaura Medical to Present at the Maxim Group Emerging Growth in A.I. ConferenceGlobeNewswireLoughborough, England, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and
- 3y agoABTNMRDNVOPLNT+1Wearable Devices and IoT Revolutionize Healthcare Monitoring and Weight ManagementPR NewswireFinancialBuzz.com News Commentary NEW YORK, Sept. 18, 2023 /PRNewswire/ -- Among the many technologies that are now being integrated with healthcare systems are wearable devices. In effect, medical device manufacturers
- 3y agoGRMNIRTCNMRDPLNT+1Weight-loss Programs Level Up With Smart Wearable DevicesPR NewswireFinancialBuzz.com News Commentary NEW YORK, Sept. 15, 2023 /PRNewswire/ -- The wearable technology market has evolved in recent years into a major tech segment, in large part thanks to consumer market growth which is
- 3y agoNMRDNemaura Medical Provides Update on Nasdaq Compliance Status and ProcessGlobeNewswireLOUGHBOROUGH, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic
- 3y agoAHCOIRTCNMRDTNDM+1Wearable Sensors Can be Valuable Assets on the Weight Loss JourneyPR NewswireFinancialBuzz.com News Commentary NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Obesity is a major medical issue that increases the risk of many other diseases and health complications including heart disease, diabetes, high
- 3y agoNMRDNemaura Medical Announces Interim Results from its Collaboration with the UK's National Health Service on its Metabolic Health & Weight Loss ProgramGlobeNewswireLOUGHBOROUGH, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic
- 3y agoNMRDNemaura Medical Announces Participation at HLTH 2023, Las VegasGlobeNewswireLOUGHBOROUGH, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic
- 3y agoNMRDNemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim ResultsGlobeNewswireLOUGHBOROUGH, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors
- 3y agoNMRDNemaura Medical Announces SFDA Approval of sugarBEAT®GlobeNewswireLoughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable,
- 3y agoNMRDNemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business UpdateGlobeNewswireLoughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable,
- 3y agoNMRDNemaura Medical Secures $6.5m in Non-Dilutive FundingGlobeNewswireLoughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting
- 3y agoNMRDNemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023GlobeNewswireLoughborough, England, July 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable,
- 3y agoNMRDNemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56 Corporations in the U.S. Signed Up for Pilots in June 2023GlobeNewswireLOUGHBOROUGH, June 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on non-invasive wearable sensors and personalized weight reduction
- 3y agoNMRDNemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023GlobeNewswireLOUGHBOROUGH, June 22, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura"), a medical technology company focused on non-invasive wearable sensors and personalized weight reduction programs,
- 3y agoNMRDNemaura Medical to Participate in Fireside Chat Hosted by EF HuttonGlobeNewswireLOUGHBOROUGH, March 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors
- 3y agoNMRDNemaura Includes Insulin on List of Drugs Eligible for EU DuoPack License AgreementGlobeNewswireLOUGHBOROUGH, March 15, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors
- 3y agoNMRDNemaura Medical Announces Receipt of Notice from NasdaqGlobeNewswireLOUGHBOROUGH, March 09, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and
- 3y agoNMRDNemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business UpdateGlobeNewswireLoughborough, England, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable
- 3y agoNMRDNemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual ConferenceGlobeNewswireLoughborough, England, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting
- 3y agoNMRDNemaura Medical Announces Closing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private PlacementGlobeNewswireLOUGHBOROUGH, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and
- 3y agoNMRDNemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private PlacementGlobeNewswireLOUGHBOROUGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable sensors and
- 3y agoNMRDNemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleetBusiness WireNemaura to integrate its proBEATTM glucose sensors with HealthFleet's proven RestoreHealth wellness program targeted at U.S. Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company
- 3y agoNMRDNemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleetGlobeNewswireNemaura to integrate its proBEATTM glucose sensors with HealthFleet's proven RestoreHealth wellness program targeted at U.S. market LOUGHBOROUGH, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD)
- 3y agoNMRDNemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of ParticipantsBusiness WireAverage weight loss of 3.7 pounds and an average BMI reduction of 0.6 after 10 weeks in initial patients Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company focused on
- 3y agoNMRDNemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of ParticipantsGlobeNewswireAverage weight loss of 3.7 pounds and an average BMI reduction of 0.6 after 10 weeks in initial patients LOUGHBOROUGH, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the
- 3y agoNMRDNemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual ConferenceGlobeNewswireLoughborough, England, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and
- 3y agoNMRDNemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022GlobeNewswireLoughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and
- 3y agoNMRDNemaura Commences Pilot Program of Miboko with the NHS in the United KingdomGlobeNewswireLOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic
- 3y agoNMRDNemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business UpdateGlobeNewswireLoughborough, England, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable,
- 4y agoNMRDNemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors ConferenceGlobeNewswireLoughborough, England, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and
- 4y agoABTDXCMMDTNMRD+1Medical Wearable Devices are in High Demand New Technologies Improve Patient Monitoring CapabilitiesPR NewswireFinancialBuzz.com News Commentary NEW YORK, Oct. 13, 2022 /PRNewswire/ -- The medical device industry is growing steadily thanks to new technologies as well as an emerging medical infrastructure around the world. Some of
- 4y agoNMRDNemaura Receives Provisional Purchase Order from Middle East Licensee TPMENAGlobeNewswireLOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising noninvasive wearable
- 4y agoNMRDNemaura Medical to Present at the MicroCap Rodeo Windy City Roundup 2022 ConferenceGlobeNewswireLoughborough, England, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coach
- 4y agoABTMASIMDTNMRDMinimally Invasive Medical Devices Reshape Patient Care CapabilitiesPR NewswireFinancialBuzz.com News Commentary NEW YORK, Sept. 29, 2022 /PRNewswire/ -- Among the numerous technologies that help transform the medical device market are the Internet of Things (IoT), machine learning and advanced 3D printing. For instance, IoT is i
- 4y agoAHCOGRMNMDTNMRD+1Wearable Medical Devices Revolutionize How Patient Data Can be TrackedPR NewswireFinancialBuzz.com News Commentary NEW YORK , Sept. 28, 2022 /PRNewswire/ -- Some of the fastest growing segments in the medical device market by application include diagnostic devices like patient-monitoring systems, MRI machines, diagnostic imaging e
- 4y agoABTDXCMNMRDPODD+1Cutting Edge Medical Devices Offer Innovative Options for DiabeticsPR NewswireFinancialBuzz.com News Commentary NEW YORK, Sept. 27, 2022 /PRNewswire/ -- In the modern technologically-driven healthcare landscape, the business model of medical device companies has evolved from device makers to problem solvers. In effect, medical d
- 4y agoNMRDNemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura's Diabetes Management Program in the U.S.GlobeNewswireCHICAGO and LOUGHBOROUGH, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising noninvasive wearable diagnostic devices and supporting p
- 4y agoNMRDNemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment ConferenceGlobeNewswireLoughborough, England, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coac
- 4y agoNMRDNemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business UpdateGlobeNewswireLoughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting
- 4y agoNMRDIBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Dr. Faz Chowdhury, CEO of Nemaura Medical Inc.GlobeNewswireLOS ANGELES, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the late
- 4y agoAAPLABTAHCOIRTC+1Wearable Medical Devices Ease the Burden of Remote Patient CarePR NewswireFinancialBuzz.com News Commentary NEW YORK, Aug. 1, 2022 /PRNewswire/ -- Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that is collected and measured by means of digital devices such as portables, wearables
- 4y agoABTDXCMGRMNMASI+1Medical Wearables Development Reaches Fever PitchPR NewswireFinancialBuzz.com News Commentary NEW YORK, July 21, 2022 /PRNewswire/ -- The wearable technology sector continues to prove its potential across various industries. Advancements in sensor technology are making such products more appealing in industrial